TABLE 2.
PARAMETER | Pre-contrast T2, DWI, T1 | Post-contrast T1 + gadolinium chelate | 18FDG PET |
---|---|---|---|
MORPHOLOGY
| |||
Solid | Restricted diffusion | Tumor enhancement | Increased visual avidity for18FDG* |
Cystic | Hyperintense on T2 and DWI (T2-shine through) | No contrast enhancement | No central 18FDG avidity; exception: single paraspinal |
Homogenous | Uniform T2 and DWI signal | Uniform contrast enhancement | N/A |
Heterogeneous | Varying T2 and DWI signal | Varying contrast enhancement | N/A |
Presence of necrosis(y/n), areas of decreased/absent contrast enhancement within lesion | Heterogenous/hyperintense on T2 and DWI (T2-shine through) | Decreased or absent areas of contrast enhancement | No 18FDG avidity and fluid noted present on CT or MRI |
Tumor margins | Well-defined = distinct; Ill-defined = indistinct tumor boundary | N/A since all margins on PETare ill defined | |
| |||
TUMOR EXTENT
| |||
Infiltration of adjacent organs (y/n) | Tumor/areas of visualized 18FDG avidity extends beyond organ of origin and infiltrates adjacent structures | ||
Extension across midline(y/n) | Tumor/18FDG avidity extends beyond contralateral margin of the contralateral vertebral body | ||
Encasement of vessels (y/n) | Tumor/18FDG avidity surrounding vessel more than 270°. For 18FDG PET, MRI or CT was used for anatomic correlation | ||
Tumor thrombosis (y/n) | Enlarged vein with altered signal on T2 and DWI | Enlarged vein with focal area of intraluminal enhancement | Focal linear 18FDG uptake within a vein that was either enlarged or in contiguity solid tumoral tissue |
| |||
METASTASES
| |||
Solid organ (liver, spleen, kidney and pancreas) (y/n) | Hyperintense on T2 and DWI | Lesions with Gd-enhancement and washout on delayed scans | Obvious 18FDG avidity beyond background visually within the organ* |
Bone (y/n) | Hyperintense on T2 and DWI | Tumor enhancement | Visual 18FDG avidity either diffusely or focally within lesion* |
Lymph node (y/n) | Short axis >1cm with loss of normal kidney bean shape | Visual 18FDG avidity within the lymph node despite size* | |
| |||
FINAL DIAGNOSIS | Most appropriate diagnosis based on imaging features |
If equivocal, than an ROI was placed within the lesion of concern, mean SUVmax taken and compared to mediastinal blood pool or hepatic background. If the mean SUVmax was greater than 2.5, this was considered concerning for tumoral involvement or metastatic disease.